Fractionated dose of cisplatin (CDDP) and vinorelbine (VNB) chemotherapy for elderly patients with advanced non-small cell lung cancer: Phase II trial

Lung Cancer

Volumn 54, Issue 3, 2006, Pages 353-357

  Buffoni, Lucio ^a   Dongiovanni, Diego ^a   Barone, Carla ^a   Fissore, Camilla ^a   Ottaviani, Davide ^a   Dongiovanni, Vincenzo ^a   Grillo, Raffaella ^a   Salvadori, Angelica ^a   Birocco, Nadia ^a   Schena, Marina ^a   Bertetto, Oscar ^a  

^a MOLINETTE HOSPITAL   (Italy)

Author keywords

Chemotherapy; Cisplatin; Elderly; Lung cancer; NSCLC; Toxicity; Vinorelbine

Indexed keywords

CISPLATIN; NAVELBINE;

ADULT; ALOPECIA; AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; ASTHENIA; BLOOD TOXICITY; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DEATH; DISEASE COURSE; DRUG TOLERABILITY; FEBRILE NEUTROPENIA; FEMALE; HUMAN; HUMAN TISSUE; LEUKOCYTE COUNT; LEUKOPENIA; LUNG EDEMA; LUNG NON SMALL CELL CANCER; MALE; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PHLEBITIS; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TIME SERIES ANALYSIS; TREATMENT FAILURE; VOMITING; WORLD HEALTH ORGANIZATION;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; TREATMENT OUTCOME; VINBLASTINE;

EID: 33750375824     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2006.08.013     Document Type: Article

References (27)

1. Vercelli M., Quaglia A., Casella C., Parodi S., Capocaccia R., and Martinez-Garcia C. Cancer in elderly patients: the population-based indexes in Europe (incidence, mortality, survival and prevalence). Ann Oncol 9 Suppl. 3 (1998) 55
2. World Health Organization. WHO handbook for reporting results of cancer treatment, Geneva; 1997.
3. Yancik R. Cancer burne in the aged. An epidemiologic and demographic overview. Cancer 80 (1997) 1273
4. Lee-Chiong Jr. T.L., and Matthay R.A. Lung cancer in the elderly patient. Clin Chest Med 14 (1993) 453
5. Earle C.C., Venditti L.N., Neumann P.J., Gelberg R.D., Weinstein M.C., Potosky A.L., et al. Who gets chemotherapy for metastatic lung cancer?. Chest 117 (2000) 1239
6. Balducci L., and Extermann M. Management of cancer in the older person: a practical approach. Oncologist 5 (2000) 224
7. Gridelli C. Chemotherapy of advanced non-small cell lung cancer in the elderly: an update. Crit Rev Oncol Hematol 35 (2000) 219
8. Sorenson S., Grimelius B., and Nygren P. A systematic overview of chemotherapy effects in non-small cell lung cancer. Acta Oncol 40 (2001) 327
9. Non-Small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ 311 (1995) 899
10. Hainsworth J.D., Burris III H.A., Lichty S., Morrisey L.H., Barton Jh., Bradof J.T., et al. Weekly docetaxel in the treatment of elderly patients with advanced non-small cell lung carcinoma. A Minnie Pearl Cancer Research Network phase II trial. Cancer 89 (2000) 328
11. Shepherd F.A., Abratt R.P., Anderson H., Gatzmeier U., Anglin G., and Iglesias J. Gemcitabine in the treatment of elderly patients with advanced non-small cell lung cancer. Semin Oncol 24 Suppl. 7 (1997) 50
12. The Elderly Lung Cancer Vinorelbine Italian Study Group. Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small cell lung cancer. J Natl Cancer Inst 91 (1999) 66
13. Feliu E., Lopez-Gomez L., Madronal C., Espinosa E., Espinosa J., Garcia-Giron C., et al. Gemcitabine plus vinorelbine in non-small cell lung carcinoma patients age 70 or older or patients who cannot receive cisplatin. Cancer 86 (1999) 1463
14. Frasci G., Lorusso V., Comella P., Nicolella G., Bianco A., De Cataldis G., et al. Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small cell lung cancer. J Clin Oncol 18 (2000) 2529
15. Cubillo A., Cornide M., Lopez J.L., Molina R., Feliu J., Espinosa E., et al. Renal tolerance to cisplatin in patients 70 years and older. Am J Oncol 24 (2001) 192
16. Kelly K., Giarritta S., Hayes S., Akerley W., Hesketh P., Wozniak A., et al. Should older patients receive combination chemotherapy for advanced stage non-small cell lung cancer? An analysis of Southwest Oncology Trials 9509 and 9308. Proc Am Soc Clin Oncol 20 (2001) 329a [Abstract 1313]
17. Lippe P., Silva R.R., Giuliodori L., Cancellieri M.A., Battelo N., Massacesi C., et al. Advanced non-small cell lung cancer in the elderly: effective well tolerated weekly gemcitabine and cisplatin regimen. A pilot study. Minerva Med 91 (2000) 53
18. Thyss A., Saudes L., Otto J., Creisson A., Gaspard M.M., Dassonville O., et al. Renal tolerance of cisplatin in patients more than 80 years old. J Clin Oncol 12 (1994) 2121
19. Fidias P., Supko J.G., Martins R., Boral A., Carey R., Grossband M., et al. A phase II study of weekly paclitaxel in elderly patients with advanced non-small cell lung cancer. Clin Cancer Res 7 (2001) 3942
20. Monfardini S. Medical oncology. Eur J Cancer Suppl. 7 (2001) 253
21. Gridelli C., Perrone F., Cigolari S., Manzione L., Piantedosi F., Barbera S., et al. The MILES (Multicenter Italian Lung Cancer in the Elderly Study). Phase 3 trial: gemcitabine and vinorelbine vs. vinorelbine and vs. gemcitabine in elderly advanced non-small cell lung cancer. Proc Am Soc Clin Oncol 20 (2001) 308 [Abstract 1230]
22. Bizette G.A., Gralla R.J., and Rittenberg C.N. Does older age ethnic group influence survival or response in patients in clinical trials for non-small cell lung cancer?. Proc Am Soc Clin Oncol 14 (1995) 160 [Abstract 333]
23. Crino L., Novello S., Migliorino M.R., Foggi P., Gridelli C., Galli L., et al. A phase III randomized trial comparing three platinum-based doublets in advanced non-small cell lung cancer: impact of PS = 2 vs. 0 or 1 and age ≥70 vs. <70 on chemotherapy outcome. Proc Am Soc Clin Oncol 21 (2002) 315 [Abstract 1258]
24. Kubota K., Furuse K., Kawahara M., Kodama N., Oyawara M., Takada M., et al. Cisplatin-based combination chemotherapy for elderly patients with non-small cell lung cancer. Cancer Chemother Pharmacol 40 (1997) 469
25. Langer J.C., Manola J., Bernardo P., Kugler J.W., Bonomi P., Cella D., et al. Cisplatin-based therapy for elderly patients with non-small cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial. J Natl Cancer Inst 94 (2002) 173
26. Nguyen B., Sandler A., and Denham C. The safety and efficacy of gemcitabine plus cisplatin in elderly chemonaive patients (age >70 years) as compared to those with age <70 years. Proc Am Soc Clin Oncol 18 (1999) 471a [Abstract 1818]
27. Rinaldi M., DeMarinis F., Ardizzoni A., Pernucci M.C., Bruzzi P., Salvati F., et al. Correlation between age and prognosis in patients with advanced non-small cell lung cancer prognosis with cisplatin containing chemotherapy: a retrospective multicenter study. Ann Oncol 5 Suppl. 8 (1994) 58